Carles Díez(@diez_carles) 's Twitter Profile Photo

Excellent talk on fibrosis in heart failure. We come closer to understanding HF phenotypes independently from ejection fraction and closer to structural and functional impairments!

Excellent talk on fibrosis in heart failure. We come closer to understanding HF phenotypes independently from ejection fraction and closer to structural and functional impairments! #HeartFailure2019
account_circle
Caitlin Cheshire(@drcaitcheshire) 's Twitter Profile Photo

Honoured to have been awarded runner-up in the Young Investigator Award-Clinical at for our work on size matching by predicted heart mass in heart transplant. Many thanks to senior author Stephen Pettit for the ongoing guidance & support.

Honoured to have been awarded runner-up in the Young Investigator Award-Clinical at #Heartfailure2019 for our work on size matching by predicted heart mass in heart transplant. Many thanks to senior author @drstephenpettit for the ongoing guidance & support.
account_circle
Prof. Petros Nihoyannopoulos(@PetrosProf) 's Twitter Profile Photo

.important take home message by Stephan Von Bardeleben 2019 . During the past decade we have sorted TAVI, now over the past 5-years we are sorting the mitral valve, not done yet! We are now in the beginning of the next decade of the tricuspid valve!

.important take home message by Stephan Von Bardeleben #HeartFailure2019. During the past decade we have sorted TAVI, now over the past 5-years we are sorting the mitral valve, not done yet! We are now in the beginning of the next decade of the tricuspid valve! #HeartFailure
account_circle
Mercedes Rivas-Lasarte(@m_rivaslasarte) 's Twitter Profile Photo

We have just presented the results of the -HF trial. A strategy of LUS-guided follow up in HF patients may improve outcomes. Thanks European Society of Cardiology for this incredible opportunity!

We have just presented the results of the #LUS-HF trial. A strategy of LUS-guided follow up in HF patients may improve outcomes. Thanks @escardio for this incredible opportunity! #HeartFailure2019
account_circle
Dr Rani Khatib FESC(@DrRaniKhatib) 's Twitter Profile Photo

Heart failure medicines are not being optimized in acute setting OR when recommendations made they are not acted upon AND adherence assessment doesn’t seem to be part of routine practice. More missed opportunities.

Heart failure medicines are not being optimized in acute setting OR when recommendations made they are not acted upon AND adherence assessment doesn’t seem to be part of routine practice. More missed opportunities. #HeartFailure2019
account_circle
Lidia López García(@Lidiloga) 's Twitter Profile Photo

Patients diagnosed with acute HF and adverse reaction to acenocumarol, the TTR<60% was associated with an increased risk of overdosage and bleeding, lower level of haemoglobin and higher readmisssion at 30 days.
Manuel Méndez

Patients diagnosed with acute HF and adverse reaction to acenocumarol, the TTR<60% was associated with an increased risk of overdosage and bleeding, lower level of haemoglobin and higher readmisssion at 30 days. 
@mendez_bailon
 #HeartFailure2019 #clinicoentwitter
account_circle
Paola Morejón Barragán(@paomorejon) 's Twitter Profile Photo

📌TRANSITION study
🚨Initiation of sacubitril/valsartan with reduced ejection fraction patients stabilised after an AHF event, either in hospital 🏥 or shortly after discharge, is feasible.

onlinelibrary.wiley.com/doi/pdf/10.100…

📌TRANSITION study
🚨Initiation of sacubitril/valsartan with reduced ejection fraction patients stabilised after an AHF event, either in hospital 🏥 or shortly after discharge, is feasible.
#HeartFailure2019 
onlinelibrary.wiley.com/doi/pdf/10.100…
account_circle